Blue Faery President Andrea Wilson spoke at an FDA mini-symposium titled Liver-Directed Therapies for Hepatocellular Carcinoma (HCC). Ms. Wilson was the only female and only non-doctor who spoke at the one-day event. She was honored to contribute to the patient’s perspective about clinical trial eligibility. See her short talk on YouTube.